Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke

@article{Shah2018DeviceCV,
  title={Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke},
  author={R. Shah and M. Nayyar and I. Jovin and Abdul Rashid and B. R. Bondy and T. Fan and M. Flaherty and S. Rao},
  journal={Annals of Internal Medicine},
  year={2018},
  volume={168},
  pages={335-342}
}
  • R. Shah, M. Nayyar, +5 authors S. Rao
  • Published 2018
  • Medicine
  • Annals of Internal Medicine
  • Stroke is a leading cause of death and long-term disability worldwide (1). Approximately one third of ischemic strokes have no identifiable cause and are classified as cryptogenic (1, 2). Many studies show that patent foramen ovale (PFO) is associated with cryptogenic stroke, particularly in young patients (3). Thus, transcatheter device closure of the defect may reduce the risk for recurrent stroke, and observational studies have suggested its efficacy (4, 5). However, the first 3 randomized… CONTINUE READING
    42 Citations
    Correction: Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale
    • Medicine
    • Annals of Internal Medicine
    • 2018
    Closure versus Medical Therapy for Patent Foramen Ovale in Patients with Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.
    • 4
    The Fragility Index in Randomized Controlled Trials for Patent Foramen Ovale Closure in Cryptogenic Stroke.
    • M. Topcuoglu, E. Arsava
    • Medicine
    • Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
    • 2019
    • 2
    Recurrent cerebrovascular events in patients after percutaneous closure of patent foramen ovale.
    Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence
    • 3

    References

    SHOWING 1-10 OF 40 REFERENCES
    Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    • 702
    • PDF
    Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
    • 771
    • PDF
    Long‐Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
    • 412
    • PDF
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
    • 417
    • PDF
    Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
    • 147
    • PDF